Erenumab effectively induces Medication Overuse Headache remission in chronic migraine patients. Monthly 140 mg injections show significant...
Vous n'êtes pas connecté
WEDNESDAY, Sept. 18, 2024 -- Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in patients with nonopioid chronic migraine (CM) and MOH, according to a study published online...
Erenumab effectively induces Medication Overuse Headache remission in chronic migraine patients. Monthly 140 mg injections show significant...
Erenumab effectively induces Medication Overuse Headache remission in chronic migraine patients. Monthly 140 mg injections show significant...
Highlights: Erenumab 140 mg achieved 69.1% Medication Overuse Headache remission at 6 months Erenumab 70 mg also
WEDNESDAY, Sept. 18, 2024 -- Break Wave lithotripsy (BWL) is a safe and effective noninvasive stone therapy, according to a study published online...
WEDNESDAY, Sept. 18, 2024 -- For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced...
TUESDAY, Sept. 17, 2024 -- A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with...
THURSDAY, Sept. 5, 2024 -- For older adults, respiratory syncytial virus (RSV) vaccination is effective against RSV hospitalization, according to a...
WEDNESDAY, Sept. 11, 2024 -- For women and men, abdominal adipose tissue is associated with chronic musculoskeletal pain, according to a study...
MONDAY, Sept. 16, 2024 -- Among youth with chronic pain, a number of individuals are diagnosed with anxiety and depression when compared with their...
FRIDAY, Sept. 6, 2024 -- Machine learning can identify patients who are at risk for persistent opioid use after surgery, according to a study...